News
News releases on April 2, 2026, page 22
Every news release public companies put out on April 2, 2026 (UTC): 2,871 news releases, newest first. Open any release to read it.
FF Announces Fourth Quarter and Full Year 2025 Financial Results
Apr 2, 2026
Faraday Future Announces Its Latest Robot, the FX Aegis Quadruped, has Completed Its Full Compliance Certification in the United States
Faraday Future Intelligent Electric Inc. · Apr 2, 2026
F3 Uranium Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
F3 Uranium Corp · Apr 2, 2026
F3 Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Apr 2, 2026
EXL announces a strategic services collaboration with Google Cloud
ExlService Holdings, Inc. · Apr 2, 2026
Everus Acquires SE&M, Leading Contractor in Southeast Region
Apr 2, 2026
European Wax Center's EWC TREAT® Dual-Sided Dry Brush Wins 2026 NewBeauty Award
Apr 2, 2026
European Wax Center's EWC TREAT® Dual-Sided Dry Brush Wins 2026 NewBeauty Award
Apr 2, 2026
European Wax Center's EWC TREAT® Dual-Sided Dry Brush Wins 2026 NewBeauty Award
Apr 2, 2026
European Wax Center's EWC TREAT® Dual-Sided Dry Brush Wins 2026 NewBeauty Award
Apr 2, 2026
European Wax Center's EWC TREAT® Dual-Sided Dry Brush Wins 2026 NewBeauty Award
Apr 2, 2026
European Wax Center's EWC TREAT® Dual-Sided Dry Brush Wins 2026 NewBeauty Award
Apr 2, 2026
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Plat...
Apr 2, 2026
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nas...
Esperion Therapeutics, Inc. · Apr 2, 2026
ESAB Corporation Announces CFO Transition
Apr 2, 2026
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
Apr 2, 2026
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
Entera Bio Ltd. · Apr 2, 2026
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
Apr 2, 2026
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
Apr 2, 2026
Endeavour To Announce Its Q1 2026 Results On 30 April 2026
Apr 2, 2026
Encore Capital Group to Announce First Quarter 2026 Financial Results on May 6
Encore Capital Group Inc · Apr 2, 2026
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
Apr 2, 2026
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
Apr 2, 2026
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
Apr 2, 2026
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
Apr 2, 2026
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
Apr 2, 2026
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
Apr 2, 2026
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
Apr 2, 2026
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
Apr 2, 2026
Elemental Royalty to Commence Trading on the Toronto Stock Exchange
Apr 2, 2026
Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure
Apr 2, 2026
Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure
Apr 2, 2026
Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure
Apr 2, 2026
Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure
Apr 2, 2026
Ecopetrol S.A. and Refinería de Cartagena S.A.S. Execute Agreement with the Nation for the Outstanding Payment of the FEPC Corresponding ...
Apr 2, 2026
Ecopetrol S.A. and Refinería de Cartagena S.A.S. Execute Agreement with the Nation for the Outstanding Payment of the FEPC Corresponding ...
Apr 2, 2026
ECARX Announces Audited 2025 Full-Year Financial Results
ECARX Holdings Inc. · Apr 2, 2026
Eastern Bankshares, Inc. Announces First Quarter 2026 Earnings Release Date, Conference Call and Webcast
Eastern Bankshares, Inc. · Apr 2, 2026
Dr. Calvin Choi, Founder of AMTD IDEA, Re‑Appointed as the Chief President of the Hong Kong Island Youth United Association
Apr 2, 2026
Dr. Calvin Choi, Founder of AMTD IDEA, Re‑Appointed as the Chief President of the Hong Kong Island Youth United Association
Apr 2, 2026
Dorman Products, Inc. Names Kevin Olsen Chairman of The Board
Apr 2, 2026
Dorman Products, Inc. Names Kevin Olsen Chairman of The Board
Apr 2, 2026
Dorman Products, Inc. Names Kevin Olsen Chairman of The Board
Apr 2, 2026
Dorman Products, Inc. Names Kevin Olsen Chairman of The Board
Dorman Products, Inc. · Apr 2, 2026
Dorman Products, Inc. Names Kevin Olsen Chairman of The Board
Apr 2, 2026
Dorman Products, Inc. Names Kevin Olsen Chairman of The Board
Apr 2, 2026
Dorman Products, Inc. Names Kevin Olsen Chairman of The Board
Apr 2, 2026
Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy
Apr 2, 2026
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4: 30 p.m. Eastern Time
Apr 2, 2026
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4: 30 p.m. Eastern Time
DexCom, Inc. · Apr 2, 2026
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4: 30 p.m. Eastern Time
Apr 2, 2026
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4: 30 p.m. Eastern Time
Apr 2, 2026
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4: 30 p.m. Eastern Time
Apr 2, 2026
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4: 30 p.m. Eastern Time
Apr 2, 2026
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4: 30 p.m. Eastern Time
Apr 2, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Deliv...
Dermata Therapeutics, Inc. · Apr 2, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Deliv...
Apr 2, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Deliv...
Apr 2, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Deliv...
Apr 2, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Deliv...
Apr 2, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Deliv...
Apr 2, 2026
Del Taco Brings Back Fan Favorite Big Fat Tacos and Introduces Del Flipz
Jack In the Box Inc. · Apr 2, 2026
Date Set For Moody's Earnings Release And Investor Teleconference
Apr 2, 2026
Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development
Apr 2, 2026
Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development
Apr 2, 2026
Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development
Apr 2, 2026
Daktronics to Ring Nasdaq Stock Market Closing Bell on April 8, 2026
Daktronics, Inc. · Apr 2, 2026
Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Dissemin...
Apr 2, 2026
Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Dissemin...
Apr 2, 2026
Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Dissemin...
Cycurion, Inc. · Apr 2, 2026
Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Dissemin...
Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Commercial Vehicle Group, Inc. · Apr 2, 2026
CVG Announces Sale-Leaseback Transaction to Improve Balance Sheet Strength
Apr 2, 2026
CVD Equipment Corporation Completes Sale of its SDC Division
CVD Equipment Corporation · Apr 2, 2026
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Impo...
Curanex Pharmaceuticals Inc · Apr 2, 2026
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Impo...
Apr 2, 2026
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Impo...
Apr 2, 2026
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Impo...
Apr 2, 2026
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Impo...
Apr 2, 2026
CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of...
Apr 2, 2026
CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of...
Apr 2, 2026
CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of...
Apr 2, 2026
CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of...
Apr 2, 2026
CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of...
Apr 2, 2026
CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of...
Apr 2, 2026
Cre8 Enterprise Limited Announces Acquisition of Upperhand Investment Limited, Expanding Presence in Japan
Cre8 Enterprise Limited · Apr 2, 2026
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
Apr 2, 2026
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
Coya Therapeutics, Inc. · Apr 2, 2026
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
Apr 2, 2026
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
Apr 2, 2026
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
Apr 2, 2026
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
Apr 2, 2026
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
Apr 2, 2026